Cannabis
DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose
Miami, Florida–(Newsfile Corp. – October 19, 2022) – DoseConnect™, a first-of-its-kind talent company solely focused on psychedelic therapeutics. Blending organizational strategy, systems thinking, and talent acquisition grounded in conscious connection, DoseConnect™ is built to help companies in this space scale for hyper-growth, and will be sponsoring the Tech Stage Wonderland Miami Conference by Microdose on November 3rd, 2022.
Visit us at the Tech Stage on November 3rd, or through the conference in the Exhibitor Hall to learn more about how our team can help build companies and create conscious cultures from the ground up because we know what it takes to find and land a dream team.
“We are thrilled to launch our services in support of the psychedelic medicine industry and couldn’t think of a better opportunity to do this than at Wonderland in 2022” – Dom Farnan, DoseConnect™ CEO
Get tickets: Use DOSECONNECT20 to save 20% on tickets. Click this link to have it automatically applied: https://tickets.microdose.buzz/attendance/event/index/41737/EN?promocodes=DOSECONNECT20
About DoseConnect™
Driven towards future healing and wellbeing, DoseConnect™ is a first-of-its-kind talent company solely focused on psychedelic therapeutics. Blending organizational strategy, systems thinking, and talent acquisition grounded in conscious connection, DoseConnect™ is built to help companies in this space scale for hyper-growth. Working directly with founders, visionaries and high-level operators, the team at DoseConnect™ helps companies with everything from human resources systems and compliance to growth culture transformation. DoseConnect™ is founded by Dom Farnan, CEO and Erica Downing, COO – the dynamic duo behind DotConnect™, a 2021 Inc5000 company focused on talent acquisition and retention. For more information, please visit www.DoseConnect.io.
Erica Downing
([email protected])
About Wonderland by Microdose Psychedelic Insights
Wonderland: Miami will offer the industry a unique in-person convergence of business, science, music, and emerging technologies. The event is a thought-leadership platform and an opportunity to connect with influential leaders in science, policy, and business. It will also act as a launching pad for innovative content connected to the psychedelic medicine space, providing compelling entertainment and collaboration opportunities for attendees.
About Microdose Psychedelics Insights
Microdose Psychedelic Insights is your guide to the psychedelic medicine industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry to the forefront of modern medicine.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/141126
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Cannabis
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis5 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis4 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan4 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey